Amyloid particles facilitate surface-catalyzed cross-seeding by acting as promiscuous nanoparticles
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Significance: The formation of disease-associated fibrillar amyloid structures can be accelerated by preformed amyloid seeds. This seeding process is thought to occur solely through elongation at amyloid fibril ends, resulting in the templated propagation of the protein conformation encoded in the seeds. We demonstrate that amyloid seeding does not always proceed through templated elongation and show that amyloid seeds are nanoparticles that can accelerate the formation of new heterologous amyloid without templating the protein conformation encoded in the seeds. We provide experimentally testable criteria to distinguish seeding through a templated elongation mechanism from surface catalysis and present mechanistic insights into the amyloid seeding and cross-seeding phenomenon. These findings have wide implications for our understanding of the molecular basis of amyloid cross-interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382 · cited 5×
“A particles are associated with numerous neurodegenerative and/or age-related human disease such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and type 2 diabetes mellitus (1, 2).”
InfluentialRisk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
A constant rate of spontaneous mutation in DNA-based microbes.
Drake, J. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7160 · Cited by 1,199
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130 · cited 1×
“For amyloidogenic proteins involved in misfolded protein diseases, heterologous amyloid particles would potentially allow the formation of a pallet of conformational variants or strains, with different levels of toxicity and infectious potential (46, 47).”
How does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492 · cited 3×
“…to be statistically correlated with the occurrence of a number of other amyloid associated diseases (Biessels et al., 2006; Daniele et al., 2018; Sims-Robinson et al., 2010), while the full-length Sup35 protein can become a transmissible prion and can be regarded as a functional amyloid…”
BackgroundLövestam, S., Schweighauser, M., Matsubara, T., Murayama, S., Tomita, T., Ando, T., Hasegawa, K., Yoshida, M., Tarutani, A., Hasegawa, M., et al. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13110 · Cited by 183
Beal, D. M., Tournus, M., Marchante, R., Purton, T. J., Smith, D. P., Tuite, M. F., Doumic, M., & Xue, W.-F. (2020) · iScience · doi:10.1016/j.isci.2020.101512 · Cited by 29
Self-citation
Cited by
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
Ohgita, T., Kono, H., Morita, I., Oyama, H., Shimanouchi, T., Kobayashi, N., & Saito, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-38070-4 · Cited by 20
Direct Demonstration of Seed Size-Dependent α-Synuclein Amyloid Amplification
Sakunthala, A., Datta, D., Navalkar, A., Gadhe, L., Kadu, P., Patel, K., Mehra, S., Kumar, R., Chatterjee, D., Devi, J., et al. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c01650 · Cited by 16
Xue, W.-F. (2025) · Structure · doi:10.1016/j.str.2024.11.007 · Cited by 14
Self-citation
Metadata
- Authors
- Koloteva-Levine, N., Aubrey, L. D., Marchante, R., Purton, T. J., Hiscock, J. R., Tuite, M. F., & Xue, W.-F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2021-08-30
- Volume
- 118
- Issue
- 36
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3198165147
- Cited by
- 42
- References
- 7
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.